1. Home
  2. LMAT vs NVCR Comparison

LMAT vs NVCR Comparison

Compare LMAT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$84.45

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$13.44

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
NVCR
Founded
1983
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.5B
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
LMAT
NVCR
Price
$84.45
$13.44
Analyst Decision
Buy
Buy
Analyst Count
6
6
Target Price
$101.83
$28.42
AVG Volume (30 Days)
205.7K
1.8M
Earning Date
11-06-2025
10-30-2025
Dividend Yield
0.95%
N/A
EPS Growth
27.40
N/A
EPS
2.32
N/A
Revenue
$240,866,000.00
$642,269,000.00
Revenue This Year
$15.17
$9.75
Revenue Next Year
$9.07
$5.62
P/E Ratio
$36.20
N/A
Revenue Growth
13.07
11.17
52 Week Low
$71.42
$10.70
52 Week High
$105.55
$32.06

Technical Indicators

Market Signals
Indicator
LMAT
NVCR
Relative Strength Index (RSI) 47.79 59.06
Support Level $83.33 $12.30
Resistance Level $88.28 $13.97
Average True Range (ATR) 2.21 0.56
MACD 0.22 0.09
Stochastic Oscillator 34.00 76.23

Price Performance

Historical Comparison
LMAT
NVCR

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: